quinoxalines has been researched along with Anxiety in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 20 (54.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekker, A; Kang, S; Li, J; Ye, JH | 1 |
| Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS | 1 |
| Bhatt, S; Devadoss, T; Jindal, A; Mahesh, R | 4 |
| Aguiar, JC; Guimarães, FS; Lisboa, SF; Magesto, AC; Resstel, LB | 1 |
| Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C | 1 |
| Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Akar, F; Bektas, E; Erden, F; Komsuoglu Celikyurt, I; Mutlu, O; Tanyeri, P; Ulak, G | 1 |
| Gupta, D; Kurhe, Y; Radhakrishnan, M; Thangaraj, D | 1 |
| An, XL; Tai, FD | 1 |
| Devadoss, T; Kurhe, Y; Mahesh, R | 2 |
| Devadoss, T; Mahesh, R; Modak, N; Pandey, DK | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ | 1 |
| Bakhtiari, A; Salari, AA; Solati, J | 1 |
| Bhatt, S; Devadoss, T; Jindal, A; Kumar, B; Mahesh, R; Pandey, DK | 1 |
| Chung, E; Li, S; Quock, RM | 1 |
| Guimarães, FS; Jardim, MC | 1 |
| Aguiar, DC; Beijamini, V; de Lucca, AC; Guimarães, FS; Moreira, FA | 1 |
| Del Bel, EA; Echeverry, MB; Guimarães, FS; Iyomasa, M; Spolidório, PC | 1 |
| Chappell, A; Diaz, MR; DuBois, DW; Läck, AK; McCool, BA | 1 |
| da Cunha, IC; de Lima, TC; Faria, MS; Ferraz, A; Lopes, AP; Marino Neto, J; Paschoalini, MA; Steffens, SM; Vargas, JC | 1 |
| Arizmendi-García, Y; Crespo-Ramírez, M; Flores-Gracia, C; Fuxe, K; Gallegos-Cari, A; Hernández-Gómez, AM; Jacobsen, KX; Lara-García, D; Nuche-Bricaire, A; Pérez de la Mora, M | 1 |
| Bell, R; Donaldson, C; Gracey, D | 1 |
| Karcz-Kubicha, M; Liljequist, S | 1 |
| Belonga, KL; Carter, DB; Im, HK; Im, WB; Jacobsen, EJ; Petke, JD; Sethy, VH; Stelzer, LS; Tang, AH; TenBrink, RE; VonVoigtlander, PF | 1 |
| Balster, RL; Cristello, AF; Wiley, JL | 1 |
| Davis, M; Walker, DL | 1 |
| Członkowska, A; Płaźnik, A; Siemiatkowski, M | 1 |
| Belonga, KL; Carter, DB; Im, HK; Im, WB; Jacobsen, EJ; Mickelson, JW; Petke, JD; Sethy, VH; Stelzer, LS; Tang, AH; TenBrink, RE; VonVoigtlander, PF; Zhong, WZ | 1 |
| Kurasawa, M; Nakamura, K; Shirane, M | 1 |
| Blotta, C; Flores, E; Funes, A; Gargiulo, PA; Landa, AI; Martínez, G; Ropero, C | 1 |
| Higgins, GA; Jones, BJ; Oakley, NR | 1 |
1 review(s) available for quinoxalines and Anxiety
| Article | Year |
|---|---|
Role of nitric oxide in brain regions related to defensive reactions.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anxiety; Behavior, Animal; Brain; Cats; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escape Reaction; Excitatory Amino Acid Antagonists; Free Radical Scavengers; GABA Modulators; Imidazoles; Immunohistochemistry; Maze Learning; Midazolam; Models, Biological; NADPH Dehydrogenase; Nitric Oxide; Oxadiazoles; Quinoxalines; Rats | 2005 |
2 trial(s) available for quinoxalines and Anxiety
| Article | Year |
|---|---|
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
34 other study(ies) available for quinoxalines and Anxiety
| Article | Year |
|---|---|
Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats.
Topics: Alcoholism; Amino Acid Transport System X-AG; Animals; Antidepressive Agents; Anxiety; Ceftriaxone; Central Nervous System Depressants; Depression; Ethanol; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Habenula; In Vitro Techniques; Kainic Acid; Male; Maze Learning; Nerve Tissue Proteins; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Substance Withdrawal Syndrome; Swimming; Tetrodotoxin | 2018 |
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline | 2013 |
Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Molecular Structure; Quinoxalines; Receptors, Serotonin, 5-HT3 | 2013 |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Topics: Animals; Anxiety; Apomorphine; Arachidonic Acids; Bicuculline; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; GABA-A Receptor Antagonists; Male; Maze Learning; Nitric Oxide Synthase; Oxadiazoles; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2013 |
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Fluoxetine; Guinea Pigs; Mice; Motor Activity; Olfactory Bulb; Paroxetine; Quinoxalines; Rats; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Swimming | 2013 |
Summaries for patients. Does varenicline help people with depression quit smoking?
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain | 2014 |
Effects of 7-NI and ODQ on memory in the passive avoidance, novel object recognition, and social transmission of food preference tests in mice.
Topics: Animals; Anxiety; Arginine; Avoidance Learning; Exploratory Behavior; Food Preferences; Indazoles; Male; Memory; Mice; Mice, Inbred BALB C; Motor Activity; Oxadiazoles; Quinoxalines; Smell; Social Behavior | 2014 |
Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Female; Guinea Pigs; Male; Mice; Motor Activity; Myenteric Plexus; Quinoxalines; Rats, Wistar; Serotonin; Serotonin 5-HT3 Receptor Antagonists | 2014 |
AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anxiety; Arginine Vasopressin; Dizocilpine Maleate; Glutamine; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrrolidines; Quinoxalines | 2014 |
QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
Topics: Adrenal Cortex Hormones; Animal Feed; Animals; Antidepressive Agents; Anxiety; Brain; Depression; Dietary Fats; Glutathione; Hypothalamo-Hypophyseal System; Leptin; Male; Malondialdehyde; Maze Learning; Mice; Mice, Obese; Oxidative Stress; Quinoxalines; Serotonin 5-HT3 Receptor Antagonists; Sucrose; Swimming | 2015 |
Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Injuries, Traumatic; Depression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Maze Learning; Quinoxalines; Rats; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists | 2017 |
Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Drug Evaluation, Preclinical; Lipopolysaccharides; Male; Maze Learning; Mice; Piperazines; Quinoxalines; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists | 2017 |
Novel 5-HT
Topics: Animals; Anxiety; Brain Chemistry; Brain-Derived Neurotrophic Factor; Depression; Diet, High-Fat; Hippocampus; Insulin Resistance; Male; Mice; Motor Activity; Obesity; Quinoxalines; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Swimming; Tumor Suppressor Protein p53 | 2017 |
Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Depressive Disorder; Disease Models, Animal; Feeding and Eating Disorders; Male; Mice; Motor Activity; Obsessive-Compulsive Disorder; Quinoxalines; Rats; Rats, Wistar; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin 5-HT3 Receptor Antagonists | 2016 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |
5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Exploratory Behavior; Male; Microinjections; Piperazines; Piperidones; Prefrontal Cortex; Quinoxalines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds | 2011 |
Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Emotions; Mice; Olfactory Bulb; Ondansetron; Paroxetine; Photoperiod; Quinoxalines; Rats; Rats, Wistar; Reserpine; Serotonin 5-HT3 Receptor Antagonists; Swimming | 2012 |
Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test.
Topics: Animals; Anxiety; Behavior, Animal; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; Male; Mice; Nitrous Oxide; Oxadiazoles; Periodicity; Phosphodiesterase Inhibitors; Purinones; Quinoxalines | 2004 |
Role of glutamate ionotropic receptors in the dorsomedial hypothalamic nucleus on anxiety and locomotor behavior.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anxiety; Dorsomedial Hypothalamic Nucleus; Male; Motor Activity; Quinoxalines; Rats; Rats, Wistar; Receptors, Glutamate | 2004 |
Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
Topics: Analysis of Variance; Animals; Anxiety; Cyclic GMP; Dentate Gyrus; Dose-Response Relationship, Drug; Guanylate Cyclase; Hippocampus; Indazoles; Male; Maze Learning; Microinjections; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Punishment; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2007 |
Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala.
Topics: Administration, Inhalation; Amygdala; Animals; Anxiety; Central Nervous System Depressants; Data Interpretation, Statistical; Electrophysiology; Ethanol; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamates; Male; Microinjections; Neurotransmitter Agents; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Synapses; Synaptic Transmission; Tetrodotoxin | 2007 |
The microinjection of AMPA receptor antagonist into the accumbens shell, but not into the accumbens core, induces anxiolysis in an animal model of anxiety.
Topics: Analysis of Variance; Animals; Anxiety; Avoidance Learning; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fear; Female; Microinjections; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA | 2008 |
Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release.
Topics: Amygdala; Animals; Anxiety; Avoidance Learning; Electroshock; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Gastrins; In Vitro Techniques; Male; Maze Learning; Microinjections; Motor Activity; Nerve Endings; Nerve Net; Quinoxalines; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Dopamine D1; Sincalide; Tetragastrin | 2007 |
Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour.
Topics: Agonistic Behavior; Animals; Anxiety; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Pyridines; Quinoxalines; Serotonin Receptor Agonists; Social Behavior | 1995 |
Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Quinoxalines; Receptors, AMPA | 1995 |
High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex.
Topics: Animals; Anxiety; Benzodiazepines; Binding, Competitive; Brain; Bridged Bicyclo Compounds, Heterocyclic; Chlorides; Flunitrazepam; GABA Agonists; GABA Antagonists; Molecular Conformation; Molecular Structure; Oxadiazoles; Pentylenetetrazole; Quinoxalines; Rats; Receptors, GABA-A | 1996 |
Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Topics: Amino Acids; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Modulators; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phencyclidine; Punishment; Quinoxalines; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1995 |
Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acoustic Stimulation; Afferent Pathways; Amygdala; Animals; Anxiety; Avoidance Learning; Conditioning, Classical; Darkness; Excitatory Amino Acid Antagonists; Fear; Hypothalamus; Male; Photic Stimulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Reflex, Startle | 1997 |
Some behavioral effects of AMPA/kainate receptor agonist and antagonists.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Conflict, Psychological; Drinking Behavior; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid | 1997 |
Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Biological Availability; Cell Line; Cerebellum; Convulsants; Cyclic GMP; Drug Evaluation, Preclinical; GABA Agonists; Imidazoles; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Molecular Conformation; Pentylenetetrazole; Piperazines; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Structure-Activity Relationship; Urea | 1999 |
Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anxiety; Behavior, Animal; Conditioning, Operant; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; Motor Activity; Nootropic Agents; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA | 2000 |
Effects of selective NMDA and non-NMDA blockade in the nucleus accumbens on the plus-maze test.
Topics: Animals; Anxiety; Defecation; Excitatory Amino Acid Antagonists; Male; Motor Activity; Nucleus Accumbens; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Stereotaxic Techniques | 2002 |
Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Conflict, Psychological; Injections; Interpersonal Relations; Male; Microinjections; Piperazines; Pyrimidines; Quinoxalines; Raphe Nuclei; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Tetrahydronaphthalenes | 1992 |